Cargando…

Non-coding cancer driver candidates identified with a sample- and position-specific model of the somatic mutation rate

Non-coding mutations may drive cancer development. Statistical detection of non-coding driver regions is challenged by a varying mutation rate and uncertainty of functional impact. Here, we develop a statistically founded non-coding driver-detection method, ncdDetect, which includes sample-specific...

Descripción completa

Detalles Bibliográficos
Autores principales: Juul, Malene, Bertl, Johanna, Guo, Qianyun, Nielsen, Morten Muhlig, Świtnicki, Michał, Hornshøj, Henrik, Madsen, Tobias, Hobolth, Asger, Pedersen, Jakob Skou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: eLife Sciences Publications, Ltd 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5440169/
https://www.ncbi.nlm.nih.gov/pubmed/28362259
http://dx.doi.org/10.7554/eLife.21778
_version_ 1783238027698503680
author Juul, Malene
Bertl, Johanna
Guo, Qianyun
Nielsen, Morten Muhlig
Świtnicki, Michał
Hornshøj, Henrik
Madsen, Tobias
Hobolth, Asger
Pedersen, Jakob Skou
author_facet Juul, Malene
Bertl, Johanna
Guo, Qianyun
Nielsen, Morten Muhlig
Świtnicki, Michał
Hornshøj, Henrik
Madsen, Tobias
Hobolth, Asger
Pedersen, Jakob Skou
author_sort Juul, Malene
collection PubMed
description Non-coding mutations may drive cancer development. Statistical detection of non-coding driver regions is challenged by a varying mutation rate and uncertainty of functional impact. Here, we develop a statistically founded non-coding driver-detection method, ncdDetect, which includes sample-specific mutational signatures, long-range mutation rate variation, and position-specific impact measures. Using ncdDetect, we screened non-coding regulatory regions of protein-coding genes across a pan-cancer set of whole-genomes (n = 505), which top-ranked known drivers and identified new candidates. For individual candidates, presence of non-coding mutations associates with altered expression or decreased patient survival across an independent pan-cancer sample set (n = 5454). This includes an antigen-presenting gene (CD1A), where 5’UTR mutations correlate significantly with decreased survival in melanoma. Additionally, mutations in a base-excision-repair gene (SMUG1) correlate with a C-to-T mutational-signature. Overall, we find that a rich model of mutational heterogeneity facilitates non-coding driver identification and integrative analysis points to candidates of potential clinical relevance. DOI: http://dx.doi.org/10.7554/eLife.21778.001
format Online
Article
Text
id pubmed-5440169
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher eLife Sciences Publications, Ltd
record_format MEDLINE/PubMed
spelling pubmed-54401692017-05-24 Non-coding cancer driver candidates identified with a sample- and position-specific model of the somatic mutation rate Juul, Malene Bertl, Johanna Guo, Qianyun Nielsen, Morten Muhlig Świtnicki, Michał Hornshøj, Henrik Madsen, Tobias Hobolth, Asger Pedersen, Jakob Skou eLife Cancer Biology Non-coding mutations may drive cancer development. Statistical detection of non-coding driver regions is challenged by a varying mutation rate and uncertainty of functional impact. Here, we develop a statistically founded non-coding driver-detection method, ncdDetect, which includes sample-specific mutational signatures, long-range mutation rate variation, and position-specific impact measures. Using ncdDetect, we screened non-coding regulatory regions of protein-coding genes across a pan-cancer set of whole-genomes (n = 505), which top-ranked known drivers and identified new candidates. For individual candidates, presence of non-coding mutations associates with altered expression or decreased patient survival across an independent pan-cancer sample set (n = 5454). This includes an antigen-presenting gene (CD1A), where 5’UTR mutations correlate significantly with decreased survival in melanoma. Additionally, mutations in a base-excision-repair gene (SMUG1) correlate with a C-to-T mutational-signature. Overall, we find that a rich model of mutational heterogeneity facilitates non-coding driver identification and integrative analysis points to candidates of potential clinical relevance. DOI: http://dx.doi.org/10.7554/eLife.21778.001 eLife Sciences Publications, Ltd 2017-03-31 /pmc/articles/PMC5440169/ /pubmed/28362259 http://dx.doi.org/10.7554/eLife.21778 Text en © 2017, Juul et al http://creativecommons.org/licenses/by/4.0/ This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use and redistribution provided that the original author and source are credited.
spellingShingle Cancer Biology
Juul, Malene
Bertl, Johanna
Guo, Qianyun
Nielsen, Morten Muhlig
Świtnicki, Michał
Hornshøj, Henrik
Madsen, Tobias
Hobolth, Asger
Pedersen, Jakob Skou
Non-coding cancer driver candidates identified with a sample- and position-specific model of the somatic mutation rate
title Non-coding cancer driver candidates identified with a sample- and position-specific model of the somatic mutation rate
title_full Non-coding cancer driver candidates identified with a sample- and position-specific model of the somatic mutation rate
title_fullStr Non-coding cancer driver candidates identified with a sample- and position-specific model of the somatic mutation rate
title_full_unstemmed Non-coding cancer driver candidates identified with a sample- and position-specific model of the somatic mutation rate
title_short Non-coding cancer driver candidates identified with a sample- and position-specific model of the somatic mutation rate
title_sort non-coding cancer driver candidates identified with a sample- and position-specific model of the somatic mutation rate
topic Cancer Biology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5440169/
https://www.ncbi.nlm.nih.gov/pubmed/28362259
http://dx.doi.org/10.7554/eLife.21778
work_keys_str_mv AT juulmalene noncodingcancerdrivercandidatesidentifiedwithasampleandpositionspecificmodelofthesomaticmutationrate
AT bertljohanna noncodingcancerdrivercandidatesidentifiedwithasampleandpositionspecificmodelofthesomaticmutationrate
AT guoqianyun noncodingcancerdrivercandidatesidentifiedwithasampleandpositionspecificmodelofthesomaticmutationrate
AT nielsenmortenmuhlig noncodingcancerdrivercandidatesidentifiedwithasampleandpositionspecificmodelofthesomaticmutationrate
AT switnickimichał noncodingcancerdrivercandidatesidentifiedwithasampleandpositionspecificmodelofthesomaticmutationrate
AT hornshøjhenrik noncodingcancerdrivercandidatesidentifiedwithasampleandpositionspecificmodelofthesomaticmutationrate
AT madsentobias noncodingcancerdrivercandidatesidentifiedwithasampleandpositionspecificmodelofthesomaticmutationrate
AT hobolthasger noncodingcancerdrivercandidatesidentifiedwithasampleandpositionspecificmodelofthesomaticmutationrate
AT pedersenjakobskou noncodingcancerdrivercandidatesidentifiedwithasampleandpositionspecificmodelofthesomaticmutationrate